sec filing
DM
NASDAQ · DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
Financial Services · Shell Companies
$10.16
Up+$0.02 (+0.17%)
Updated Sep 14, 2026, 11:56 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 518.58M
- P/E ratio
- -54.87
- Dividend yield
- 0.00%
- 52-week range
- $9.94 – $10.21
- Volume
- 1.6K
- Avg. volume
- 429.72K
Price performance
DMII price history
1M range · 18 trading sessions · Daily adjusted prices
DMII closed at $10.16 after 18 trading sessions, up 0.42% for the selected period.
- Last close
- $10.16
- Period change
- +0.42%
- Period low
- $10.12
- Period high
- $10.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $10.1758 | $10.1758 | $10.1628 | $10.1628 | 1.6K |
| Sep 10, 2026 | $10.18 | $10.18 | $10.16 | $10.17 | 26.77K |
| Sep 9, 2026 | $10.21 | $10.21 | $10.16 | $10.16 | 4.16K |
| Sep 8, 2026 | $10.165 | $10.17 | $10.16 | $10.165 | 4.32K |
| Sep 4, 2026 | $10.17 | $10.17 | $10.17 | $10.17 | 892 |
| Sep 3, 2026 | $10.185 | $10.185 | $10.16 | $10.17 | 4.68K |
| Sep 2, 2026 | $10.17 | $10.185 | $10.16 | $10.17 | 25.35K |
| Sep 1, 2026 | $10.15 | $10.16 | $10.145 | $10.155 | 123.05K |
| Aug 31, 2026 | $10.14 | $10.15 | $10.13 | $10.15 | 62.6K |
| Aug 28, 2026 | $10.14 | $10.14 | $10.14 | $10.14 | 317 |
| Aug 27, 2026 | $10.12 | $10.14 | $10.12 | $10.14 | 207.49K |
| Aug 26, 2026 | $10.1201 | $10.135 | $10.1196 | $10.12 | 288.74K |
| Aug 25, 2026 | $10.21 | $10.21 | $10.1468 | $10.15 | 80.39K |
| Aug 24, 2026 | $10.14 | $10.15 | $10.14 | $10.15 | 152.72K |
| Aug 21, 2026 | $10.14 | $10.14 | $10.14 | $10.14 | 1.06K |
| Aug 20, 2026 | $10.13 | $10.14 | $10.12 | $10.14 | 5.9K |
| Aug 19, 2026 | $10.13 | $10.13 | $10.12 | $10.12 | 1.3K |
| Aug 18, 2026 | $10.12 | $10.12 | $10.12 | $10.12 | 432 |
Latest DMII news
The latest Smart Investors Daily articles mentioning DMII.
Stock researchCompany · Overview
DMII research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition II Corp is a blank check Company.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.